The largest database of trusted experimental protocols

Bv711 anti cd107a clone h4a3

Manufactured by BioLegend

BV711-anti-CD107A (clone H4A3) is a fluorochrome-conjugated antibody that recognizes the cell surface protein CD107A (also known as LAMP-1). It can be used for the detection and analysis of CD107A-expressing cells in flow cytometry applications.

Automatically generated - may contain errors

2 protocols using bv711 anti cd107a clone h4a3

1

Isolation and Phenotyping of CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ex vivo (d0) and peptide-expanded (d6) CD8+ T cells were isolated from PBMCs and LNMCs using EasySep Human CD8+ T Cell Isolation Kit (StemCell Technologies) and stimulated with 4 nM APC-pHLA tetramer at 37°C for 4 hours in R10 with BV711-anti-CD107A (clone H4A3, Biolegend) to measure cytolytic degranulation. Cells were stained with BUV395-anti-CD8 (clone RPA-T8, BD Biosciences), Live/Dead Blue (Thermo Fisher), fixed and permeabilized with Cytofix/Cytoperm (BD Biosciences), and stained for intracellular PE-anti-perforin (clone B-D48, Biolegend) and PE-CF594-anti-granzyme B (clone GB11, BD Biosciences). FMO controls were used to establish gating. Experimental negative controls were pre-treated with 50 nM dasatinib 30 minutes before tetramer stimulation to prevent activation, and experimental positive controls were treated with PMA and ionomycin (eBioscience Cell Stimulation Cocktail, Thermo Fisher). Samples were analyzed by flow cytometry. Representative gating and controls are shown in fig. S5A and C. Samples with fewer than 40 live HIV-specific pHLA-tetramer+ CD8+ T cells at d0 in both PB and LN were excluded from downstream analyses.
+ Open protocol
+ Expand
2

Isolation and Phenotyping of CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ex vivo (d0) and peptide-expanded (d6) CD8+ T cells were isolated from PBMCs and LNMCs using EasySep Human CD8+ T Cell Isolation Kit (StemCell Technologies) and stimulated with 4 nM APC-pHLA tetramer at 37°C for 4 hours in R10 with BV711-anti-CD107A (clone H4A3, Biolegend) to measure cytolytic degranulation. Cells were stained with BUV395-anti-CD8 (clone RPA-T8, BD Biosciences), Live/Dead Blue (Thermo Fisher), fixed and permeabilized with Cytofix/Cytoperm (BD Biosciences), and stained for intracellular PE-anti-perforin (clone B-D48, Biolegend) and PE-CF594-anti-granzyme B (clone GB11, BD Biosciences). FMO controls were used to establish gating. Experimental negative controls were pre-treated with 50 nM dasatinib 30 minutes before tetramer stimulation to prevent activation, and experimental positive controls were treated with PMA and ionomycin (eBioscience Cell Stimulation Cocktail, Thermo Fisher). Samples were analyzed by flow cytometry. Representative gating and controls are shown in fig. S5A and C. Samples with fewer than 40 live HIV-specific pHLA-tetramer+ CD8+ T cells at d0 in both PB and LN were excluded from downstream analyses.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!